3-10249378-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014760.4(TATDN2):c.178G>A(p.Glu60Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014760.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TATDN2 | NM_014760.4 | c.178G>A | p.Glu60Lys | missense_variant | 2/8 | ENST00000448281.7 | NP_055575.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TATDN2 | ENST00000448281.7 | c.178G>A | p.Glu60Lys | missense_variant | 2/8 | 1 | NM_014760.4 | ENSP00000408736.2 | ||
ENSG00000272410 | ENST00000437082.5 | n.7G>A | non_coding_transcript_exon_variant | 1/8 | 2 | ENSP00000402783.1 | ||||
ENSG00000289763 | ENST00000699225.1 | c.*12G>A | downstream_gene_variant | ENSP00000514219.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249370Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135046
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461028Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726768
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.178G>A (p.E60K) alteration is located in exon 2 (coding exon 1) of the TATDN2 gene. This alteration results from a G to A substitution at nucleotide position 178, causing the glutamic acid (E) at amino acid position 60 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at